FDA Warns of Fatal Liver Injuries Tied to Drug It Wants Pulled From Market

(MedPage Today) -- The FDA on Tuesday warned that postmarketing data has turned up dozens of serious cases of drug-induced liver injury (DILI) associated with avacopan (Tavneos), a vasculitis drug that the agency wants removed from the market...
Source
MedPage Today
Opens original article in a new tab



